|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 EGP | -1.97% |
|
+7.97% | +30.70% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 1.53 | 1.53 | 1.96 |
| Spread/Res. | -2.61% | -2.61% | -23.98% |
| Spread/Supp. | +12.03% | +40.57% | +42.99% |
| Support | 1.33 | 1.06 | 1.042 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MCRO Stock
- Charts Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
